CancerQuest | Interview with Dr. Steven Sherman

Dr. Steven Sherman
Naguib Samaan Distinguished Professor and Chair
Department of Endocrine Neoplasia and Hormonal Disorders
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center

Dr. Sherman's research focus is thyroid cancer. His work addresses a wide range of topics around care and treatment of thyroid cancer patients that include: the molecular biology of thyroid cancer, development of genetic tests for thyroid cancer, and the development of targeted therapies to treat the disease. In our wide-ranging interview, Dr. Sherman discusses a variety of topics related to his research and medical research in general.

Questions and Answers

	About Dr. Steven Sherman(Time: 11 sec)
	What first got you interested in cancer research, in particular, thyroid cancer?(Time: 1 min 16 sec)
	What are the challenges of treating endocrine cancers that distinguish them from other cancer types?(Time: 1 min 55 sec)
	How does the biology of endocrine cancer differ from other types of cancer?(Time: 1 min 29)
	How has the individualization of cancer treatment impacted patients (with thyroid cancer)?(Time: 1 min 56 sec)
	What do you see as the main ethical considerations of genetic testing?(Time: 3 min 10 sec)
	What lies in the future of genetic testing for thyroid cancer?(Time: 1 min 54 sec)
	Does the development of targeted cancer treatments affect the way that new physicians will have to approach their patients?(Time: 2 min 44 sec)
	Does your research/medical practice involve training undergraduates or graduate students?(Time: 2 min 13 sec)
	Could you describe the activation of RET via translocation?(Time: 2 min 43 sec)
	What needs to be done to increase the awareness and enrollment in clinical trials?(Time: 3 min 27 sec)
	How do the model systems use to study cancer influence the development of treatments and our understanding of the biology of the disease?(Time: 4 min 45 sec)
	What are the obstacles to national and international medical research collaborations and how might they be overcome?(Time: 2 min 10 sec)
	What is your opinion on epigenetics as way of controlling gene expression?(Time: 2 min 24 sec)
	What do you see as the new era for clinical trials?(Time: 1 min 4 sec)